Filing Details

Accession Number:
0001179110-11-003652
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-28 19:35:18
Reporting Period:
2011-02-24
Filing Date:
2011-02-28
Accepted Time:
2011-02-28 19:35:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1302443 E Rick Winningham Theravance, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-24 135,950 $8.53 692,223 No 4 M Direct
Common Stock Disposition 2011-02-24 93,100 $21.45 599,123 No 4 S Direct
Common Stock Acquisiton 2011-02-25 135,850 $8.53 734,973 No 4 M Direct
Common Stock Disposition 2011-02-25 50,200 $22.22 684,773 No 4 S Direct
Common Stock Disposition 2011-02-25 42,000 $22.74 642,773 No 4 S Direct
Common Stock Acquisiton 2011-02-28 101,752 $8.53 744,525 No 4 M Direct
Common Stock Disposition 2011-02-28 29,800 $22.49 714,725 No 4 S Direct
Common Stock Disposition 2011-02-28 37,200 $23.49 677,525 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-02-24 135,950 $0.00 135,950 $8.53
Common Stock Stock Option (Right to Buy) Disposition 2011-02-25 135,850 $0.00 135,850 $8.53
Common Stock Stock Option (Right to Buy) Disposition 2011-02-28 101,752 $0.00 101,752 $8.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
237,602 2011-12-08 No 4 M Direct
101,752 2011-12-08 No 4 M Direct
0 2011-12-08 No 4 M Direct
Footnotes
  1. Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c).
  2. This transaction was executed in multiple trades at prices from $20.85 to $21.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices from $21.57 to $22.56. The price reported above reflects the weighted average sale price.
  4. This transaction was executed in multiple trades at prices from $22.57 to $22.85. The price reported above reflects the weighted average sale price.
  5. This transaction was executed in multiple trades at prices from $22.09 to $22.99. The price reported above reflects the weighted average sale price.
  6. This transaction was executed in multiple trades at prices from $23.00 to $23.95. The price reported above reflects the weighted average sale price.
  7. Immediately exercisable